Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 2335: Predicting cirrhosis risk in patients with metabolic dysfunction-associated steatotic liver disease

Pasang Sherpa, Sebastian M. Armasu, Jacob A. Frank, Irene K. Yan, Kirk J. Wangensteen, Tushar Patel, Samuel O. Antwi

Cancer Res (2025) 85 (8_Supplement_1): 2335.

https://doi.org/10.1158/1538-7445.AM2025-2335

Published: 21 April 2025

View article titled, Abstract 2335: Predicting cirrhosis risk in patients with metabolic dysfunction-associated steatotic liver disease

Journal Articles

Abstract 2350: Protein biomarkers of HCC development in patients with metabolic liver disease

Ampem Darko Jnr Siaw, Sebastian M. Armasu, Jacob A. Frank, Irene K. Yan, Kirk J. Wangensteen, Tushar Patel, Samuel O. Antwi

Cancer Res (2025) 85 (8_Supplement_1): 2350.

https://doi.org/10.1158/1538-7445.AM2025-2350

Published: 21 April 2025

View article titled, Abstract 2350: Protein biomarkers of HCC development in patients with metabolic liver disease

Journal Articles

Abstract 440: BAP1 deubiquitinates ACLY to promote lipogenesis yet predisposing cholangiocarcinoma to iron overload and ferroptosis

Peyton Classon, Sophia Jaramillo, Danielle Carlson, Irene Yan, Tushar Patel, Sumera I. Ilyas, Rory L. Smoot, Gregory J. Gores, Davide Povero

Cancer Res (2024) 84 (6_Supplement): 440.

https://doi.org/10.1158/1538-7445.AM2024-440

Published: 22 March 2024

View article titled, Abstract 440: BAP1 deubiquitinates ACLY to promote lipogenesis yet predisposing cholangiocarcinoma to iron overload and ferroptosis

Journal Articles

Abstract 814: Novel strategy for aptamer-directed nanovesicle targeting in cholangiocarcinoma

Mincheng Yu, Jennifer L. Tomlinson, Emilien J. Loeuillard, Ryan D. Watkins, Caitlin B. Conboy, Shohei Takaichi, Nathan W. Werneburg, Roberto Alva-Ruiz, Amro Abdelrahman, Danielle M. Carlson, Jingchun Yang, Sumera I. Ilyas, Gregory J. Gores, Tushar Patel, Rory L. Smoot

Cancer Res (2023) 83 (7_Supplement): 814.

https://doi.org/10.1158/1538-7445.AM2023-814

Published: 04 April 2023

View article titled, Abstract 814: Novel strategy for aptamer-directed nanovesicle targeting in cholangiocarcinoma

Journal Articles

Abstract 5049: Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary tract cancer: A Swedish population-based cohort study

Lorena Marcano-Bonilla, Cathy D. Schleck, W. Scott Harmsen, Omid Sadr-Azodi, Mitesh J. Borad, Tushar Patel, Gloria M. Petersen, Terry M. Therneau, Lewis R. Roberts, Nele Brusselaers

Cancer Res (2019) 79 (13_Supplement): 5049.

https://doi.org/10.1158/1538-7445.AM2019-5049

Published: 01 July 2019

View article titled, Abstract 5049: Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary tract cancer: A Swedish population-based cohort study

Journal Articles

Abstract LB-150: Risk of de novo hepatocellular carcinoma development following use of direct acting antiviral medications for treatment of chronic hepatitis C virus infection

Samuel O. Antwi, Holly K. Van Houten, Lindsey R. Sangaralingham, Tushar Patel

Cancer Res (2019) 79 (13_Supplement): LB-150.

https://doi.org/10.1158/1538-7445.AM2019-LB-150

Published: 01 July 2019

View article titled, Abstract LB-150: Risk of de novo hepatocellular carcinoma development following use of direct acting antiviral medications for treatment of chronic hepatitis C virus infection

Journal Articles

miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival

Jong-Kook Park, Takayuki Kogure, Gerard J. Nuovo, Jinmai Jiang, Lei He, Ji Hye Kim, Mitch A. Phelps, Tracey L. Papenfuss, Carlo M. Croce, Tushar Patel, Thomas D. Schmittgen

Cancer Res (2011) 71 (24): 7608–7616.

https://doi.org/10.1158/0008-5472.CAN-11-1144

Published: 15 December 2011

View article titled, miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival

Includes: Supplementary data

Journal Articles

Abstract 1178: Involvement of MEG3, a long non-coding RNA, in hepatocellular cancer (HCC)

Chiara Braconi, Takayuki Kogure, Nicola Valeri, Gerard Nuovo, Stefan Costinean, Carlo Maria Croce, Tushar Patel

Cancer Res (2011) 71 (8_Supplement): 1178.

https://doi.org/10.1158/1538-7445.AM2011-1178

Published: 15 April 2011

View article titled, Abstract 1178: Involvement of MEG3, a long non-coding RNA, in hepatocellular cancer (HCC)

Journal Articles

Abstract 4711: Silencing of miR-221 with anti-microRNA oligonucleotides is an effective therapeutic for hepatocellular carcinoma

Jong Kook Park, Takayuki Kogure, Gerard J. Nuovo, Lei He, Ji Hye Kim, Mitch A. Phelps, Carlo M. Croce, Tushar Patel, Thomas D. Schmittgen

Cancer Res (2011) 71 (8_Supplement): 4711.

https://doi.org/10.1158/1538-7445.AM2011-4711

Published: 15 April 2011

View article titled, Abstract 4711: Silencing of miR-221 with anti-microRNA oligonucleotides is an effective therapeutic for hepatocellular carcinoma

Journal Articles

Abstract 4086: Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth

Chiara Braconi, Takayuki Kogure, Nicola Valeri, Nianyuan Huang, Pierluigi Gasparini, Gerard Nuovo, Luigi Terracciano, Carlo M. Croce, Tushar Patel

Cancer Res (2010) 70 (8_Supplement): 4086.

https://doi.org/10.1158/1538-7445.AM10-4086

Published: 15 April 2010

View article titled, Abstract 4086: Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth

Journal Articles

Abstract #1826: Efficacy of OSU-A9, a novel indole-3-carbinol derivative, in a murine model of hepatocellular carcinoma

Hany Omar, Aaron Sargeant, Dasheng Wang, Jing-Ru Weng, Samuel Kulp, Tushar Patel, Ching-Shih Chen

Cancer Res (2009) 69 (9_Supplement): 1826.

Published: 01 May 2009

View article titled, Abstract #1826: Efficacy of OSU-A9, a novel indole-3-carbinol derivative, in a murine model of hepatocellular carcinoma

Journal Articles

Over-expression of IL-6 and altered DNA methylation can regulate miRNA-370 expression in human cholangiocarcinoma

Fanyin Meng, Hania Wehbe-Janek, Roger Henson, Tushar Patel

Cancer Res (2007) 67 (9_Supplement): 1045.

Published: 01 May 2007

View article titled, Over-expression of IL-6 and altered DNA methylation can regulate miRNA-370 expression in human cholangiocarcinoma

Journal Articles

Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression

Hania Wehbe, Roger Henson, Fanyin Meng, Janna Mize-Berge, Tushar Patel

Cancer Res (2006) 66 (21): 10517–10524.

https://doi.org/10.1158/0008-5472.CAN-06-2130

Published: 01 November 2006

View article titled, Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression

Journal Articles

Over-expression of IL-6 can contribute to tumor growth by altered promoter methylation and gene expression in human cholangiocarcinoma.

Hania Wehbe, Roger Henson, Fanyin Meng, Janna Mize-Berge, Molly Lang, Tushar Patel

Cancer Res (2006) 66 (8_Supplement): 1203.

Published: 15 April 2006

View article titled, Over-expression of IL-6 can contribute to tumor growth by altered promoter methylation and gene expression in human cholangiocarcinoma.

Journal Articles

γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP–Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 Pathway

Giammarco Fava, Luca Marucci, Shannon Glaser, Heather Francis, Sharon De Morrow, Antonio Benedetti, Domenico Alvaro, Julie Venter, Cynthia Meininger, Tushar Patel, Silvia Taffetani, Marco Marzioni, Ryun Summers, Ramona Reichenbach, Gianfranco Alpini

Cancer Res (2005) 65 (24): 11437–11446.

https://doi.org/10.1158/0008-5472.CAN-05-1470

Published: 15 December 2005

View article titled, γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP–Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 Pathway

Journal Articles

Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6: A Novel Mechanism of Tumor Cell Survival

Yoko Yamagiwa, Carla Marienfeld, Fanyin Meng, Martin Holcik, Tushar Patel

Cancer Res (2004) 64 (4): 1293–1298.

https://doi.org/10.1158/0008-5472.CAN-03-2517

Published: 18 February 2004

View article titled, Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6: A Novel Mechanism of Tumor Cell Survival

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 2335: Predicting cirrhosis risk in patients with metabolic dysfunction-associated steatotic liver disease

Abstract 2350: Protein biomarkers of HCC development in patients with metabolic liver disease

Abstract 440: BAP1 deubiquitinates ACLY to promote lipogenesis yet predisposing cholangiocarcinoma to iron overload and ferroptosis

Abstract 814: Novel strategy for aptamer-directed nanovesicle targeting in cholangiocarcinoma

Abstract 5049: Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary tract cancer: A Swedish population-based cohort study

Abstract LB-150: Risk of de novo hepatocellular carcinoma development following use of direct acting antiviral medications for treatment of chronic hepatitis C virus infection

miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival

Abstract 1178: Involvement of MEG3, a long non-coding RNA, in hepatocellular cancer (HCC)

Abstract 4711: Silencing of miR-221 with anti-microRNA oligonucleotides is an effective therapeutic for hepatocellular carcinoma

Abstract 4086: Ultraconserved non-coding RNAs are involved in human hepatocellular cancer growth

Abstract #1826: Efficacy of OSU-A9, a novel indole-3-carbinol derivative, in a murine model of hepatocellular carcinoma

Over-expression of IL-6 and altered DNA methylation can regulate miRNA-370 expression in human cholangiocarcinoma

Interleukin-6 Contributes to Growth in Cholangiocarcinoma Cells by Aberrant Promoter Methylation and Gene Expression

Over-expression of IL-6 can contribute to tumor growth by altered promoter methylation and gene expression in human cholangiocarcinoma.

γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP–Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 Pathway

Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6: A Novel Mechanism of Tumor Cell Survival

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media